Quidel Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Quidel Corp (QDEL) Tops Q2 EPS by 12c, Slight Beat on Revenues
August 7, 2018 4:32 PM EDTQuidel Corp (NASDAQ: QDEL) reported Q2 EPS of $0.36, $0.12 better than the analyst estimate of $0.24. Revenue for the quarter came in at $103.2 million versus the consensus estimate of $103.11 million.
Total revenue was $103.2 million as compared to $38.3 million in the second quarter of 2017.Cardiac Immunoassay revenue was $69.9 million.Influenza revenue was $5.5 million as compared to $10.1 million in the second quarter of 2017.Reduced debt by an additional $98.6 million through convertible note exchange and accelerated Senior... More